Cutaneous vasculitis and glomerulonephritis in a patient taking the anti-TNFα agent etanercept for rheumatoid arthritis
- 30 September 2004
- journal article
- other
- Published by Elsevier BV in Joint Bone Spine
- Vol. 71 (5), 444-445
- https://doi.org/10.1016/j.jbspin.2004.05.008
Abstract
No abstract availableThis publication has 12 references indexed in Scilit:
- Hypersensitivity Vasculitis with Leukocytoclastic Vasculitis Secondary to InfliximabJournal of Clinical Gastroenterology, 2003
- A lupus-like syndrome associated with infliximab therapy.Inflammatory Bowel Diseases, 2003
- Etanercept‐induced lupus‐like syndrome in a patient with rheumatoid arthritisArthritis & Rheumatism, 2003
- Anti-TNF-?-induced systemic lupus syndromeClinical Rheumatology, 2003
- Anti-tumour necrosis factor therapy associated with cutaneous vasculitisRheumatology, 2002
- Drug-induced lupus following treatment with infliximab in rheumatoid arthritis.Lupus, 2002
- Drug-induced systemic lupus erythematosus associated with etanercept therapyThe Lancet, 2002
- Etanercept‐induced subacute cutaneous lupus erythematosusRheumatology, 2001
- Isolated digital vasculitis in a patient with rheumatoid arthritis: good response to tumour necrosis factor alpha blocking treatmentAnnals Of The Rheumatic Diseases, 2001
- Autoimmune Skin Rashes Associated with Etanercept for Rheumatoid ArthritisAnnals of Internal Medicine, 1999